For patients with tough-to-treat cancers, treatment approaches have advanced significantly over the past several decades. Scientists have made significant progress in understanding cancer biology. In this episode, sponsored by AbbVie, we explore how the discovery of biomarkers – the biological “signatures” for certain cancers – have helped create a paradigm shift in how we treat cancer by focusing on precision medicine approaches to target specific tumors. Not intended for UK audiences.

To learn more about AbbVie’s research in oncology, visit: https://www.abbvie.com/science/areas-of-focus/oncology.html.